Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • sjm
    Member
    • Nov 2009
    • 27

    #1

    many biological replicates - 'traditional' statistics vs Cuffdiff or DESeq/edgeR?

    I've read the discussions from Simon Anders and Lior Pachter intensively on these forums and understood them as best I can without extensive graduate training in mathematics or statistics :-) I grasp that correctly modeling the dispersion between biological replicates for a given treatment condition is vital for comparisons of gene expression between different treatment conditions, and that is more challenging for lower numbers of replicates.

    Before I was aware of Cuffdiff or DESeq (and actually before Cuffdiff came out), I aligned RNASeq reads using tophat and cufflinks to gain FPKM values on a 'gene-level' basis (I wasn't interested in individual isoforms). I had 6-8 biological replicates per condition, and used a traditional statistics program (Partek Genomics Suite in this case) to determine p-values between conditions and to determine a false discovery rate.

    I am in the process of comparing this approach to edgeR / DESeq to see whether comparisons between groups are generally similar. However, is there an 'a prior' statistical/mathematical reason why comparing FPKM-type data (for which, in my hands, the variance between biological replicates is normally distributed AND the variance appears to be higher when the FPKM is lower, reasonably suggesting more variance with lower read counts) between conditions is invalid or misleading?

    Thanks in advance for any thoughts.

Latest Articles

Collapse

  • SEQadmin2
    Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
    by SEQadmin2



    CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

    Despite this, “CRISPR helped turn genome editing from a specialized technique into
    ...
    07-31-2026, 11:01 AM
  • SEQadmin2
    Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
    by SEQadmin2


    Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

    The systematic characterization of the human proteome has
    ...
    07-20-2026, 11:48 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 08-06-2026, 07:41 AM
0 responses
21 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 08-03-2026, 10:13 AM
0 responses
33 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-31-2026, 02:55 AM
0 responses
43 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-24-2026, 12:17 PM
0 responses
26 views
0 reactions
Last Post SEQadmin2  
Working...